Quantcast

Latest Meningococcal vaccine Stories

2013-11-25 23:04:40

Reportbuyer.com just published a new market research report: PharmaPoint: Meningococcal Vaccines - US Drug Forecast and Market Analysis to 2022. London (PRWEB) November 25, 2013 PharmaPoint: Meningococcal Vaccines - US Drug Forecast and Market Analysis to 2022 Summary GlobalData has released its new Country report, “PharmaPoint: Meningococcal Vaccines - US Drug Forecast and Market Analysis to 2022”. Meningococcal disease is an acute infection caused by the gram-negative bacterium...

2013-10-02 23:19:21

Reportbuyer.com just published a new market research report: Global Vaccine Market Forecast to 2017. London (PRWEB) October 02, 2013 Of late, the vaccines market is burgeoning with immense activities. Big pharmaceutical companies like GSK, Pfizer, Merck etc. are struggling to maintain their revenue and operating incomes amidst patent cliffs of blockbuster drugs. In such a scenario, vaccines, which have high entry barriers for generic players and the potential to generate blockbuster...

2013-09-24 13:21:31

Clinical trial A study of 4CMenB, a new vaccine to protect against meningitis B bacteria (which can cause potentially fatal bacterial meningitis in children), shows that waning immunity induced by infant vaccination can be overcome by a booster dose at 40 months of age, according to a clinical trial published in CMAJ (Canadian Medical Association Journal). The 4CMenB vaccine, an important breakthrough in the fight against childhood meningitis, was recently licensed in Europe and is...


Word of the Day
jument
  • A beast of burden; also, a beast in general.
'Jument' ultimately comes from the Latin 'jugum,' yoke.
Related